Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma

Chun-Ting Ho, Elise Chia-Hui Tan, Pei-Chang Lee, Chi-Jen Chu, Yi-Hsiang Huang, Teh-Ia Huo, Yu-Hui Su, Ming-Chih Hou, Jaw-Ching Wu, Chien-Wei Su

Clin Mol Hepatol. 2024;30(3):406-420. Published online April 11, 2024

DOI: https://doi.org/10.3350/cmh.2024.0103

View: 2057 Download: 131 Crossref: 2

Snapshot

Immunopathogenesis of liver fibrosis in steatotic liver disease

Chaerin Woo, Won-Il Jeong

Clin Mol Hepatol. 2024;30(2):299-302. Published online February 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0113

View: 2410 Download: 96

Original Article

Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis

Gang Xu, Yu-Min Wang, Miao-Miao Ying, Sui-Dan Chen, Zong-Rui Li, Hong-Lei Ma, Ming-Hua Zheng, Jian Wu, Chunming Ding

Clin Mol Hepatol. 2021;27(2):329-345. Published online January 20, 2021

DOI: https://doi.org/10.3350/cmh.2020.0261

View: 7433 Download: 231 Web of Science: 14 Crossref: 16

Special topic: Alcoholic liver diseases The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

The lymphatic system in alcohol-associated liver disease

Reiichiro Kondo, Yasuko Iwakiri

Clin Mol Hepatol. 2020;26(4):633-638. Published online September 21, 2020

DOI: https://doi.org/10.3350/cmh.2020.0179

View: 8547 Download: 152 Web of Science: 3 Crossref: 3

Original Article

Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals

Alessio Strazzulla, Giuseppe Coppolino, Giorgio Settimo Barreca, Innocenza Gentile, Laura Rivoli, Maria Concetta Postorino, Maria Mazzitelli, Giuseppe Greco, Chiara Costa, Vincenzo Pisani, Nadia Marascio, Mariadelina Simeoni, Alfredo Focà, Giorgio Fuiano, Daniela Foti, Elio Gulletta, Carlo Torti

Clin Mol Hepatol. 2018;24(2):151-162. Published online April 24, 2018

DOI: https://doi.org/10.3350/cmh.2017.0059

View: 6874 Download: 119 Web of Science: 14 Crossref: 13

Review

Acute-on-chronic liver failure: a new syndrome in cirrhosis

Richard Moreau

Clin Mol Hepatol. 2016;22(1):1-6. Published online March 28, 2016

DOI: https://doi.org/10.3350/cmh.2016.22.1.1

View: 14844 Download: 344 Web of Science: 28 Crossref: 29

6

Hepatic tuberculosis presenting as a Large Liver mass

Yong Moon Shin, M.D.

Clin Mol Hepatol. 2010;16(2):197-200. Published online June 25, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.2.197

View: 4251 Download: 25 Crossref: 1

1

Transient elastography, true or false?

Yeon Seok Seo

Clin Mol Hepatol. 2009;15(4):431-437. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.4.431

View: 4017 Download: 26 Crossref: 2

3

Changes in liver stiffness during the course of acute hepatitis A

Yeon Seok Seo, M.D., Soon Ho Um, M.D., Sang-jun Suh, M.D., Eun Suk Jung, M.D., Jin Su Jang, M.D., Yong Dae Kwon, M.D., Sang Hoon Park, M.D., Bora Keum, M.D., Yong Sik Kim, M.D., Yoon Tae Jeen, M.D., Hoon Jai Chun, M.D., Chang Duck Kim, M.D., Ho Sang Ryu, M.D.

Clin Mol Hepatol. 2008;14(4):465-473. Published online December 31, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.4.465

View: 4991 Download: 27 Crossref: 10

7

The Korean Journal of Normal range of serum ALT level in patients with chronic hepatitis

Yeon Seok Seo

Clin Mol Hepatol. 2008;14(1):116-121. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.116

View: 4372 Download: 18

2

Cerulein Pancreatitis: Oxidative Stress, Inflammation, and Apoptosis

Hye Young Kim

Clin Mol Hepatol. 2008;12(2):74-80.

View: 1988 Download: 12

Correspondence

Correspondence to editorial on “Dynamic analysis of acute deterioration in chronic liver disease patients using modified quick sequential organ failure assessment”

Do Seon Song, Dong Joon Kim

Received June 12, 2024 Accepted June 14, 2024

DOI: https://doi.org/10.3350/cmh.2024.0448 [Epub ahead of print]

View: 513 Download: 8

1 |

Viewed By 5835	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5262	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 4953	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4922	MAFLD: How is it different from NAFLD?
Viewed By 4557	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 202	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 140	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 119	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 103	MAFLD: How is it different from NAFLD?
Cited By 93	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search